Publication Name	World Journal of Clinical Cases
Manuscript ID	94166
Country	China

Received	2024-03-13 10:32
Peer-Review Started	2024-03-13 10:32
To Make the First Decision
Return for Revision	2024-05-15 05:34
Revised	2024-06-04 14:24
Second Decision	2024-06-26 02:51
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-06-26 09:41
Articles in Press	2024-06-26 09:41
Publication Fee Transferred	2024-07-01 08:35
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-07-08 01:46
Publish the Manuscript Online	2024-07-11 09:22

ISSN	2307-8960 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Hematology
Manuscript Type	Case Report
Article Title	Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature
Manuscript Source	Unsolicited Manuscript
All Author List	Bo Deng, Rui Gao, Bing Yang, Wen-Bing Lei, Ming-Fang Xue, Ji-Shi Wang and Peng Zhao
ORCID	Author(s) ORCID Number Bo Deng http://orcid.org/0000-0003-3702-5896 Peng Zhao http://orcid.org/0000-0002-4176-3640
Funding Agency and Grant Number	Funding Agency Grant Number Science and Technology Foundation of Guizhou Provincial Health Commission gzwkj2021-152
Corresponding Author	Peng Zhao, MD, Doctor, Doctor, Department of Hematology, Affiliated Hospital of Guizhou Medical University, No. 28 Guiyi Street, Guiyang 550001, Guizhou Province, China. zhaopeng_6786262@hotmail.com
Key Words	Transplantation; PRCA; Daratumumab; Leukemia; blood-group; Case report
Core Tip	Allogeneic hematopoietic stem cell transplantation (Allo-HSCT) is currently the only possible way to cure patients with malignant hematologic diseases. In Allo-HSCT, donors have some degree of ABO blood-group incompatibility with the recipient. An outcome of ABO incompatibility caused is pure red cell aplastic anemia (PRCA). We report a 41-year-old female diagnosed with acute myeloid leukemia received a peripheral blood allo-HSCT from an HLA-matched unrelated donor in November 2013. The patient was diagnosed with PRCA three months after allo-HSCT. After failing multiple lines of treatment, daratumumab was requested. After receiving three doses of daratumumab, the patient had a marked reticulocyte response and become transfusion independent.Using of anti-CD38 therapy with daratumumab to target residual host plasma cells is safe and effective, and it can be considered in refractory recipients with PRCA after allo-HSCT secondary to ABO incompatibility.
Publish Date	2024-07-11 09:22
Citation	<p>Deng B, Gao R, Yang B, Lei WB, Xue MF, Wang JS, Zhao P. Seven-years post allogeneic hematopoietic stem cell transplantation pure red cell aplastic anemia cured with daratumumab: A case report and review of literature. <i>World J Clin Cases</i> 2024; 12(24): 5604-5612</p>
URL	https://www.wjgnet.com/2307-8960/full/v12/i24/5604.htm
DOI	https://dx.doi.org/10.12998/wjcc.v12.i24.5604

Full Article (PDF)	WJCC-12-5604-with-cover.pdf
CARE Checklist–2016	94166-CARE-Checklist-2016.pdf
Manuscript File	94166_Auto_Edited-LJH-JLW.docx
Answering Reviewers	94166-answering-reviewers.pdf
Audio Core Tip	94166-audio.mp3
Conflict-of-Interest Disclosure Form	94166-conflict-of-interest-statement.pdf
Copyright License Agreement	94166-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	94166-foundation-statement.pdf
Signed Consent for Treatment Form(s) or Document(s)	94166-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	94166-non-native-speakers.pdf
Peer-review Report	94166-peer-reviews.pdf
Scientific Misconduct Check	94166-scientific-misconduct-check.png
Scientific Editor Work List	94166-scientific-editor-work-list.pdf
CrossCheck Report	94166-crosscheck-report.pdf
CrossCheck Report	94166-crosscheck-report.png